| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,472 |
1,960 |
$283K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,349 |
1,145 |
$205K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,998 |
1,520 |
$153K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,898 |
1,745 |
$129K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,469 |
1,959 |
$94K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
426 |
350 |
$21K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
200 |
96 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
36 |
27 |
$565.72 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
40 |
27 |
$486.28 |
| 93000 |
|
29 |
20 |
$194.44 |
| 94760 |
|
3,337 |
1,483 |
$6.51 |